Are There Limits to Oncology Care? (Futility)

  • Gary R. Shapiro
Part of the Cancer Treatment and Research book series (CTAR, volume 140)


Clin Oncol Acceptable Treatment Pneumococcal Pneumonia Medical Futility Adequate Reason 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    In the Matter of Karen Ann Quinlan, an alleged incompetent 355A 2d 647; or 70 NJ 10. March 31, 1976.Google Scholar
  2. 2.
    In Re: The Conservatorship of Helga M. Wanglie, PX-91-283, Fourth Judicial District (District Court Probate Court Div.) Hennepin County, Minnesota.Google Scholar
  3. 3.
    Daar JF. Medical futility and implications for physician autonomy. Am J Law Med. 1995;21:221–240.PubMedGoogle Scholar
  4. 4.
    Crippen D. Dealing with families who demand inappropriate medical treatment for moribund patients. Intensive Care World. 1992;9: 78–80.Google Scholar
  5. 5.
    Heffner JEBrow LK, Barbieri CA. Publications in subspecialty journals on end-of-life ethics. Arch Intern Med. 1997;157:685–690.PubMedCrossRefGoogle Scholar
  6. 6.
    Blackhall LJ. Must we always use CPR? N Engl J Med. 1987;317:1281–1285.PubMedCrossRefGoogle Scholar
  7. 7.
    Tomlinson T, Brody H. Ethics and communication in do-not-resuscitate orders. N Engl J Med. 1988;318:43–46.PubMedCrossRefGoogle Scholar
  8. 8.
    Lantos JD, Singer PA, Walker RM, Gramelspacher GP, Shapiro GR, Sanchez-Gonzalez MA, Stocking CB, Miles SH, Siegler M. The illusion of futility in clinical practice. Am J Med. 1989;87:81–84.PubMedCrossRefGoogle Scholar
  9. 9.
    Shapiro GR. Unpublished Medline keyword search. Dec. 2006.Google Scholar
  10. 10.
    Faber-Lagendoen K. Resuscitation of patients with metastatic cancer. Arch Intern Med. 1991;151:235–239.CrossRefGoogle Scholar
  11. 11.
    Jeker NS, Schneidermann LJ. When families request that everything possible be done. J Med Philosophy. 1995;20:145–163.Google Scholar
  12. 12.
    Escalante CP, Martin CG, Elting LS, et al. Dyspnea in cancer patients: etiology, resource utilization and survival—implications in a managed care world. Cancer. 1996;78:1320–1325.CrossRefGoogle Scholar
  13. 13.
    Rubenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med. 1996;125:625–633.PubMedGoogle Scholar
  14. 14.
    American Medical Association Council on Ethical and Judicial Affairs. Medical futility in end-of-life care. JAMA. 1999;281: 937–941.Google Scholar
  15. 15.
    Texas Advance Directives Act of 1999. Texas Health and Safety Code ch. 166 (Vernon Supp. 1999).Google Scholar
  16. 16.
    Bedell SE, Delbanco TI, Cook EF, Epstein FH. Survival after cardiopulmonary resuscitation in the hospital. N Engl J Med. 1983;309:569–576.PubMedCrossRefGoogle Scholar
  17. 17.
    Schneiderman LJ, Jecker NS, Jonsen AR. Medical futility: its meaning and ethical implications. Ann Intern Med. 1990;112: 949–954.PubMedGoogle Scholar
  18. 18.
    Schneiderman LJ, Faber-Langendoen K, Jecker NS. Beyond futility to an ethic of care. Am J Med. 1994;96:110–114.PubMedCrossRefGoogle Scholar
  19. 19.
    Schneiderman LJ. The rise and fall of the futility movement. New Engl J Med. 2000;343:1575.PubMedCrossRefGoogle Scholar
  20. 20.
    Truog RD, Brett AS, Frader J. The problem with futility. N Engl J Med. 1992;326:1560–1564.PubMedCrossRefGoogle Scholar
  21. 21.
    Vitelli CE, Cooper K, Rogatko A, Brennan MF. Cardiopulmonary resuscitation and the patient with cancer. J Clin Oncol. 1991;9: 111–115.PubMedGoogle Scholar
  22. 22.
    Truog RD. Progress in the futility debate. J Clinical Ethics. 1995;6:128–132.Google Scholar
  23. 23.
    Solomon MZ. How physicians talk about futility: making words mean too many things. J Law Med Ethics. 1993;21:231–237.PubMedCrossRefGoogle Scholar
  24. 24.
    Curtis RJ, Park DR, Krone MR, Pearlman RA. Use of the medical futility rationale in do-not-attempt-resuscitation orders. JAMA. 1995;273:124–128.PubMedCrossRefGoogle Scholar
  25. 25.
    Council on Ethical and Judicial Affairs. Medical futility in end-of-life care: report of the Council on Ethical and Judicial Affairs. JAMA. 1999;281:937–941.CrossRefGoogle Scholar
  26. 26.
    Lofmark R, Nilstun T. Conditions and consequences of medical futility: from a literature review to a clinical model. J Med Ethics. 2002;28:115–119.PubMedCrossRefGoogle Scholar
  27. 27.
    Halevy A, Brody BA. A multi-institution collaborative policy on medical futility. JAMA 1996;276:571–574.PubMedCrossRefGoogle Scholar
  28. 28.
    Murphy DJ, Barbour E. GUIDe (Guidelines for the Use of Intensive Care in Denver): a community effort to define futile and inappropriate care. New Horiz. 1994;2:326–331.PubMedGoogle Scholar
  29. 29.
    Helft PR, Siegler M, Lantos J. The rise and fall of the futility movement. New Engl J Med. 2000;343:293–296.PubMedCrossRefGoogle Scholar
  30. 30.
    Zawacki BE. The “futility debate” and the management of Gordian knots. J Clin Ethics. 1995;6:112–127.PubMedGoogle Scholar
  31. 31.
    Katz J. The Silent World of Doctor and Patient. New York: Free Press. 1997.Google Scholar
  32. 32.
    American College of Physicians Ethics Manual Ann Intern Med. 2005;142:560–582.Google Scholar
  33. 33.
    United States Department of Health and Human Services Policy for the Protection of Human Subjects. Fed Register. Vol 46, No 17:8951. January 27, 1981.Google Scholar
  34. 34.
    President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Making Health Care Decisions: the Ethical and Legal Implications of Informed Consent in the Patient-Practitioner Relationship. Washington, DC: Government Printing Office. 1982:42–44.Google Scholar
  35. 35.
    Gert B. Morality: its nature and justification. New York: Oxford University Press. 2005.Google Scholar
  36. 36.
    Brett AS, McCulloug LB. When patients request specific interventions: defining the limits of the physician’s obligation. N Engl J Med. 1986;315:1347–1351.PubMedCrossRefGoogle Scholar
  37. 37.
    President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Deciding to Forego Life-Sustaining Treatment. Washington, DC: Government Printing Office. 1983.Google Scholar
  38. 38.
    Caralis PV, Davis B, Wright K, Marcial E. The influence of ethnicity and race on attitudes toward advance directives, life-prolonging treatments, and euthanasia. J Clin Ethics. 1993;4:155–165.PubMedGoogle Scholar
  39. 39.
    Shapiro GR. Not telling Russian immigrants the truth about cancer: cultural sensitivity or misplaced paternalism? Psycho-oncology. 1996;5:196.CrossRefGoogle Scholar
  40. 40.
    Gert B, Culver CM, Clouser KD. Bioethics: a return to fundamentals. New York: Oxford University Press. 1997.Google Scholar
  41. 41.
    Von Gruenigen VE, Daly BJ. Futility: clinical decisions at the end-of-life in women with ovarian cancer. Gynecol Oncol. 2005;97:638–644.CrossRefGoogle Scholar
  42. 42.
    Tomlinson T. Futile care in oncology: when to stop trying. Lancet Oncol. 2001;2:759–761.PubMedCrossRefGoogle Scholar
  43. 43.
    Brock DW, Wartman SA. When competent patients make irrational choices. N Engl J Med. 1990;322:1595–1599.PubMedCrossRefGoogle Scholar
  44. 44.
    Harnett PR, Moynihan TJ. “But doctor, what have I got to lose…?”. J Clin Oncol. 2001;19:3294–3296.PubMedGoogle Scholar
  45. 45.
    Doukas DJ, McCullough LB. A preventive ethics approach to counseling patients about clinical futility in the primary care setting. Arch Fam Med. 1996;5:589–592.PubMedCrossRefGoogle Scholar
  46. 46.
    Ferrell BR. Understanding the moral distress of nurses witnessing medically futile care. Oncol Nurs Forum. 2006;33:922–930.PubMedCrossRefGoogle Scholar
  47. 47.
    Jecker NS, Schneiderman U. Futility and rationing. Am J Med. 1992;92:189–196.PubMedCrossRefGoogle Scholar
  48. 48.
    Persaud R. “Futile” care in the intensive care unit. Mayo Clin Proc. 2006;81:1506–1507.PubMedGoogle Scholar
  49. 49.
    Gatter RA, Moskop JC. From futility to triage. J Med Philos. 1995;20:191–205.PubMedGoogle Scholar
  50. 50.
    DeLima M, Ghaddar H, Pierce S, Estey E. Treatment of newly-diagnosed acute myelogenous leukaemia inpatients aged 80 years and above. Br J Haematol. 1996;93:89–95.PubMedCrossRefGoogle Scholar
  51. 51.
    Kitagawa T, Hara M, Sano T, Sugimura T. The concept of tenju-gann, or “natural-end cancer.” Cancer. 1998;83:1061–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Callahan D. What Kind of Life: The limits of medical progress. New York: Simon & Schuster. 1990.Google Scholar
  53. 53.
    Slevin ML. Quality of life: philosophical questions or clinical reality? Br Med J. 1992;305:466–469.Google Scholar
  54. 54.
    Silvestri G, Pritchard R, Welch HG. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. Br Med J. 1998;317:771–775.Google Scholar
  55. 55.
    Brescia FJ. Lung cancer—a philosophical, ethical, and personal perspective. Crit Rev Oncol/Hemalol. 2001;40:139–148.CrossRefGoogle Scholar
  56. 56.
    Tsevat J, Dawson NV, Wu AW, et al. Health values of hospitalized patients 80 years or older. JAMA. 1998;279:371–375.PubMedCrossRefGoogle Scholar
  57. 57.
    Hamel MB, Teno JM, Goldman L, et al. Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized adults. Ann Intern Med. 1999;130:116–125.PubMedGoogle Scholar
  58. 58.
    Covinsky KE, Fuller JD, Yaffe K, et al. Communication and decision-making in seriously ill patients: findings of the SUPPORT project. J Am Geriatr Soc. 2000; 48:S187–S193.PubMedGoogle Scholar
  59. 59.
    Way J, Back AL, Curtis JR. Withdrawing life support and resolution of conflict with families. Br Med J. 2002;325:1342–1345.CrossRefGoogle Scholar
  60. 60.
    U.S. Preventive Services Task Force. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions. Baltimore: Williams & Wilkins. 1989.Google Scholar
  61. 61.
    Sharpe VA, Faden AI. Appropriateness in patient care: a new conceptual framework Milbank Quarterly. 1996;74:115–138.Google Scholar
  62. 62.
    Rosenbaum S, Frankford DM, Moor B, Borzi P. Who should determine when health care is medically necessary? N Engl J Med. 1999;340:229–232.PubMedCrossRefGoogle Scholar
  63. 63.
    Guyatt GH, Keller JL, Jaeschke R, et al. The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med. 1990;112:293–299.PubMedGoogle Scholar
  64. 64.
    Varma G, Stein R, Jacobson J, Briggs N, Shapiro GR. The goal of chemotherapy: little agreement between patients and their doctors. Proc AmSoc Clin Oncol. 2001;20:1542.Google Scholar
  65. 65.
    Hagerty RG, Butow PN, Ellis PA, et al. Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol. 2004;22:1721–1730.PubMedCrossRefGoogle Scholar
  66. 66.
    Gregory DR, Cotler MP. Futility: are goals the problem? Part two. Cambridge QHealthcare Ethics. 1994;3:125–134.CrossRefGoogle Scholar
  67. 67.
    Ravdin PM, Siminoff IA, Harvey JA. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol. 1998;16:515–521.PubMedGoogle Scholar
  68. 68.
    Weeks JC, Cook EF, O’Day SJ, et al. Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA. 1998;279:1709–1714.PubMedCrossRefGoogle Scholar
  69. 69.
    Daugherty C, Ratain MJ, Grochowski E, et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol.1995;13:1062–1072.PubMedGoogle Scholar
  70. 70.
    Slevin ML, Stubbs L, Plant H, et al. Attitudes to chemotherapy: comparing views of patients with those of doctors, nurses, and general public. Br Med J. 1990;300:1458–1460.CrossRefGoogle Scholar
  71. 71.
    Benner SE, Fetting JH, Brenner MH. A stopping rule for standard chemotherapy for metastatic breast cancer: lessons from a survey of Maryland medical oncologists. Cancer Invest. 1994;12:451–455.PubMedCrossRefGoogle Scholar
  72. 72.
    Gordon EJ, Daugherty CK. ‘Hitting you over the head’: oncologists’ disclosure of prognosis in advanced cancer patients. Bioethics. 2003;17:142–168.PubMedCrossRefGoogle Scholar
  73. 73.
    Baile WF, Lenzi R, Parker PA, et al. Oncologists’ attitudes toward and practices in giving bad news: an exploratory study. J Clin Oncol. 2002;20:2189–2196.PubMedCrossRefGoogle Scholar
  74. 74.
    Gattellari M, Voigt KJ, Butow PN, Tattersall MHN. When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol. 2002;20:503–513.PubMedCrossRefGoogle Scholar
  75. 75.
    Abrahm JL. The oncologist’s expanding role. Cancer. 1999;85: 1645–1648.PubMedCrossRefGoogle Scholar
  76. 76.
    Task force on cancer care at the end of life. Cancer care during the last phase of life. J Clin Oncol. 1998;16:1986–1996.Google Scholar
  77. 77.
    Schofield P, Carey M, Love A,Nehill C, Wein S. “Would you like to talk about your future treatment options?” discussing the transition from curative cancer treatment to palliative care. Palliat Med. 2006;20:397–406.PubMedCrossRefGoogle Scholar
  78. 78.
    Prendergast TJ. Futility and the common cold: how requests for antibiotics can illuminate care at the end of life. Chest. 1995;107:836–844.PubMedGoogle Scholar
  79. 79.
    Shapiro GR, Stocking CB, LaPuma J, Silverstein MD, Roland D, Siegler M. Do not resuscitate orders & life-sustaining therapy: a comparison of oncologists’ & nononcologists’ attitudes. Proc Am Soc Clin Oncol. 1988;7:269.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Gary R. Shapiro

There are no affiliations available

Personalised recommendations